Allergopharma opens new biopharmaceutical production in Reinbek

Merck's allergy business Allergopharma opened a new biopharmaceutical production facility in Reinbek, Germany, representing a €42 million investment. The 6,000 m² factory includes a 2,000 m² glass cleanroom and will support global expansion of the allergies business.

“By this €42 million investment Merck is supporting the Reinbek site to expand the allergies business on a global scale.”cphi-online.com

• 1 source
• cphi-online.comAllergopharma opens new biopharmaceutical production in... | CPHI OnlineLoginMar 4, 2017

Summarized from public sources; check the original articles before acting on it.